Greater Cannabis Company, Inc. (GCAN) intrinsic value & 10-year financials
Greater Cannabis Company, Inc. (GCAN) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 18, 2026)
- $1.14
- Market cap
- $940.5K
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- 178.8%
- ROIC (10-yr avg)
- 109.7%
- Free cash flow (FY2025)
- —
GCAN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$331.6K | $0.00 | — | — | 41.9% |
| FY2024 | — | -$179.0K | $0.00 | — | — | 23.8% |
| FY2023 | — | -$188.4K | $0.00 | — | — | 31.2% |
| FY2022 | — | -$360.3K | $0.00 | — | — | 71.1% |
| FY2021 | $12.6K | -$602.2K | — | — | -2716.9% | 160.8% |
| FY2020 | $48.0K | -$951.2K | — | — | -612.9% | 104.2% |
| FY2019 | $4.5K | -$1.6M | — | — | -11673.8% | 156.2% |
| FY2018 | $95.4K | -$839.1K | — | — | -200.2% | 178.4% |
| FY2017 | $209 | -$793.6K | — | — | -309148.3% | 326.7% |
| FY2016 | — | -$2.2K | — | — | — | 2.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Greater Cannabis Company, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Greater Cannabis Company, Inc. has earned high returns on invested capital, averaging 28.3% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Greater Cannabis Company, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Greater Cannabis Company, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.00 per share.